Cannabinoid Receptor - GPCR/G protein

Cat.No. Product Name Information

BCC6282 COR 170 COR 170

BCC7401 Tocrifluor T1117

BCC7026 Arvanil Arvanil

BCC6065 Hemopressin (human, mouse)

BCC1840 PB-22 PB-22

BCC1898 Rimonabant hydrochloride Rimonabant hHydrochloride (SR 141716A Hydrochloride) is a highly potent and selective central cannabinoid receptor (CB1) antagonist with an Ki of 1.8 nM. Rimonabant hHydrochloride (SR 141716A Hydrochloride) also inhibits Mycobacterial membrane protein Large 3 (MMPL3). Rimonabant hydrochloride

BCC1353 AM630 6-Iodopravadoline (AM630) is a selective CB2 antagonist with Ki of 31.2 nM, and displays 165-fold selectivity over CB1 receptors. AM630

BCC4414 Rimonabant Rimonabant (SR141716) is a highly potent, brain penetrated and selective central cannabinoid receptor (CB1) antagonist with a Ki of 1.8 nM. Rimonabant (SR141716) also inhibits Mycobacterial

BCC1795 Nepicastat Nepicastat (SYN117) is a selective, potent, and orally active inhibitor of dopamine-beta-hydroxylase. Nepicastat (SYN117) produces concentration-dependent inhibition of bovine (IC50=8.5 nM) and human (IC50=9 nM) dopamine-beta-hydroxylase. Nepicastat (SYN117) can cross the blood-brain barrier (BBB).

BCC7346 LY 320135

BCC7069 N-Arachidonylglycine

BCC4412 AM251 AM251 is a selective cannabinoid 1 (CB1) receptor antagonist with an IC50 of 8 nM, also acts as a potent GPR55 agonist with an EC50 of 39 nM. AM251

BCC7500 Arachidonyl serotonin

BCC7059 MAFP MAFP (Methyl Arachidonyl Fluorophosphonate) is an selective, active-site directed and irreversible inhibitor of cPLA2 and iPLA2. MAFP is also a potent irreversible inhibitor of anandamide amidase. MAFP

BCC7187 Palmitoylisopropylamide

BCC6944 AM 281 Potent, selective CB1 antagonist/inverse agonist AM 281

BCC1674 JWH 073 JWH 073

BCC7289 2-Palmitoylglycerol

BCC5971 HU 308 Potent and selective CB2 agonist HU 308

BCC7380 JTE 907 JTE 907

BCC4410 BML-190 Potent, selective CB2 ligand,BML-190 is a selective cannabinoid CB2 receptor inverse agonist with Ki of 435 nM, with 50-fold selectivity over CB1 receptor. BML-190

BCC6827 Oleamide Oleamide is an endogenous fatty acid amide which can be synthesized de novo in the mammalian nervous system, and has been detected in human plasma.

BCC7954 (±)-SLV 319 (±)-Ibipinabant ((±)-SLV319) is the racemate of SLV319. (±)-Ibipinabant ((±)-SLV319) is a potent and selective cannabinoid-1 (CB-1) receptor antagonist with an IC50 of 22 nM.

BCC2551 AM1241 AM-1241 is a selective cannabinoid CB2 receptor agonist with Ki of 3.4 nM, exhibits 82-fold selectivity over CB1 receptor. AM1241

BCC7810 NIDA 41020

BCC7313 O-1918 O-1918

BCC5807 Hemopressin (rat)

BCC6144 TC-C 14G

BCC4413 GW842166X GW842166X is a potent and selective cannabinoid receptor 2 (CB2) agonist with IC50 values of 63 and 91 nM for human and rat CB2, respectively.

BCC1828 Otenabant Otenabant is a potent and selective cannabinoid receptor CB1 antagonist with Ki of 0.7 nM, exhibits 10,000-fold greater selectivity against human CB2 receptor.

BCC1082 CP-945598 HCl Otenabant Hydrochloride is a potent and selective cannabinoid receptor CB1 antagonist with Ki of 0.7 nM, exhibits 10,000-fold greater selectivity against human CB2 receptor.

BCC1985 Taranabant Taranabant is a highly potent and selective cannabinoid 1 (CB1) receptor inverse agonist that inhibits the binding and functional activity of various agonists, with a binding Ki of 0.13 nM for the human CB1R in vitro.

BCC7746 PF 514273

BCC4411 Org 27569 Org 27569 is a potent CB1 receptor allosteric modulator, which increases agonist binding, yet blocks agonist-induced CB1 signaling.

BCC7852 MJ 15 MJ 15

BCC6114 MM-22 MM-22

Products for Cannabinoid Receptor